MongoDB shares received price-target hikes from several analysts, on the database platform's fiscal-second-quarter results that surpassed expectations.
For the quarter ended July 31, MongoDB incurred a loss of -24 cents a share, compared with -39 cents a share loss expected by analysts polled by FactSet.
Revenue rose +44% from the year-ago quarter to $198.7 million, beating analysts' expectations of $182.4 million.
Oppenheimer analyst Ittai Kidron boosted the price target to $470 from $400. Kidron affirmed his outperform rating on the company’s shares. According to Kidron, MongoDB had a "strong" July quarter, with revenue and loss per share beating estimates on the back of robust subscription revenue growth and an "impressive" performance from Atlas. He noted that Atlas is increasingly becoming MongoDB's primary growth engine. Looking forward, the analyst expects continued investment in C-level engagement to bolster long-term expansion.
Barclays analyst Raimo Lenschow hiked his price target on MongoDB shares to $505 from $420, while maintaining his overweight rating on the shares. Lenschow said that investor focus for the second quarter was on the performance of Atlas, and the results "did not disappoint." Atlas has a run rate above $400 million. He said the performance would lead to analysts revising their estimates upward. Lenschow indicated that based on MongoDB's continued product enhancements and sales motion evolution, he is sanguine that the company "has a long growth runway ahead."
Canaccord analyst David Hynes raised his price target on MongoDB shares to $290 from $245, while keeping a buy rating on the shares. According to Hynes, the stock is expensive but the company has one of the largest still growing total addressable markets. The analyst said that favorable secular trends will boost both new and expansion opportunities.
The RSI Oscillator for MDB moved out of oversold territory on March 27, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where MDB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MDB just turned positive on March 28, 2024. Looking at past instances where MDB's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDB advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .
MDB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on February 21, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MDB as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
MDB moved below its 50-day moving average on March 05, 2024 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MDB crossed bearishly below the 50-day moving average on March 11, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MDB entered a downward trend on March 28, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MDB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.450) is normal, around the industry mean (28.767). P/E Ratio (0.000) is within average values for comparable stocks, (148.690). Projected Growth (PEG Ratio) (1.654) is also within normal values, averaging (2.798). Dividend Yield (0.000) settles around the average of (0.085) among similar stocks. P/S Ratio (15.198) is also within normal values, averaging (77.911).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of MongoDB database
Industry PackagedSoftware